Business
CPC Biotech Collaborates with Multiply Labs to Advance Cell Therapy Automation
CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, has collaborated with Multiply Labs to rapidly advance the use of robotic systems in cell therapy manufacturing.
About this update from Dover Corporation
[{"type":"text","content":"DOWNERS GROVE, Ill., May 27, 2026 /PRNewswire/ -- CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, has collaborated with Multiply Labs to rapidly advance the use of robotic systems in cell therapy manufacturing.","length":318,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Dover)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Dover)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":132,"url":"https://media.zenfs.com/en/prnewswire.com/bbf9f081366d9cb6b3f4c17eec65ec43"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FT7Xz6y73UWcpSP4DGSB5g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIzMw--/https://media.zenfs.com/en/prnewswire.com/bbf9f081366d9cb6b3f4c17eec65ec43","width":400,"height":132},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/sbuNqQaMkOSoxtTRF66Eaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTIxMQ--/https://media.zenfs.com/en/prnewswire.com/bbf9f081366d9cb6b3f4c17eec65ec43","width":400,"height":132}},"href":"https://mma.prnewswire.com/media/2988912/Dover_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Automation and the use of robotics are key to accelerating patient access to advanced therapies," said Troy Ostreng, Senior Product Manager for CPC Biotech's biopharmaceutical and cell therapy and gene therapy (CGT) businesses. "To meet the growing need for faster, more efficient, high-quality cell therapy manufacturing, we're developing a first-ever aseptic connector for robotic operation."","length":423,"tagName":"p"},{"type":"text","content":"San Francisco-based Multiply Labs is a pioneer in applying robotics to the production of cell and gene therapy products. Their unique modular approach is designed to reduce manufacturing bottlenecks, minimize the risk of human contamination, and broaden access to therapies.","length":274,"tagName":"p"},{"type":"text","content":""Today, cell therapy is done completely manually," said Fred Parietti, Multiply Lab's Co-Founder and CEO. "With robotic automation, we can unlock a level of scale and affordability that has not been possible with manual approaches."","length":256,"tagName":"p"},{"type":"text","content":"Human operators, a source of contamination risk, ...